Evidence map›Paper›PMID 38932551›Full record

ReviewSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi2024

[Advances in research on organ-at-risk protection in pelvic tumor external beam radiotherapy].

Fubin Zeng, Wenjuan Zhao, Jie He, Di Chen, Huojun Zhang

Abstract readReviewEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Review in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fubin ZengDepartment of Radiation Therapy, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, P. R. China.
Wenjuan ZhaoDepartment of Radiation Therapy, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, P. R. China.
Jie HeDepartment of Radiation Therapy, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, P. R. China.
Di ChenDepartment of Radiation Therapy, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, P. R. China.
Huojun ZhangDepartment of Radiation Therapy, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The simultaneous objectives of destroying tumor cells while protecting normal pelvic organs present a dual clinical and technical challenge within the realm of pelvic tumor radiotherapy. This article reviews the latest literatures, focusing on technological innovations in key aspects of radiotherapy such as positioning, planning, and delivery. These include positioning fixation techniques, organ-at-risk avoidance irradiation, non-coplanar irradiation techniques, as well as organ displacement protection and image-guided adaptive techniques. It summarizes and discusses the research progress made in the protection of critical organs during pelvic tumor radiotherapy. The paper emphasizes technological advancements in the protection of critical organs throughout the processes of radiotherapy positioning, planning, and implementation, aiming to provide references for further research on the protection of critical organs in the external irradiation treatment of pelvic tumors.

Indexed as

Organs at RiskPelvic NeoplasmsHumansPatient PositioningPelvisRadiation InjuriesRadiation ProtectionRadiotherapyRadiotherapy Planning, Computer-AssistedExternal beam radiationOrgan-at-risk protectionPelvic tumorRadiotherapy

Identifiers

PMID38932551
PMCPMC11208645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.